ED  Maryland Health Care Product Development Corporation

http://www.techcouncilmd.com/about/mhcpdc.php





     Office Locations:

9210 Corporate Boulevard, Suite 470
Rockville, MD 20850
Phone: 240-243-4026
Fax: 240-243-4060

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Maryland Health Care Product Development Corporation (MHCPDC) is a supporting organization of the Tech Council of Maryland (TCM). Its goal is to stimulate growth of the biomedical industry in the state through early stage investment with promising Maryland biomedical and medical technology companies. The corporation will support TCM's work in Maryland and the region by assisting emerging companies with management advice, market research, technical assessments and early stage financing. The corporation's investments range in amounts from $250,000 to $1 million. MHCPDC expends significant efforts to identify and secure matching investments from commercial and state financing entities. MHCPDC's partnership approach to working with investment candidates is reflected in its ongoing, direct participation in the business development of its portfolio companies.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Blanche Johnson Investment Advisor
    Jerry L. Parrott Chairman & President
    Philip Schiff Chief Executive Officer

     

    Portfolio companies include:


      Arginetix/Corridor Pharmaceuticals
        web link


      Gliknik
        web link


      NeoDiagnostix
        web link


      Noxilizer
        web link


      Plasmonix
        web link


     

    Recent News: